Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chewing Gum vs Ondansetron for PONV Rescue
NCT07201883Phase 1Active, not recruiting
- Sponsor
- Makassed General Hospital
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial (3 arms), sponsored by Makassed General Hospital. Primary endpoint: Complete cessation of PONV with no recurrence and no rescue medication at 2 hours. Started Aug 2025; status: active, not recruiting.
Beyond the preview
Go deeper on NCT07201883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201883.